Literature DB >> 30506260

Expression of Recombinant PfCelTOS Antigen in the Chloroplast of Chlamydomonas reinhardtii and its Potential Use in Detection of Malaria.

Shabnam Shamriz1, Hamideh Ofoghi2.   

Abstract

Malaria is a serious but preventable and treatable infectious disease that is found in over 100 countries around the world. Correct and rapid diagnosis of malaria infection can rescue the patient of getting sicker and reduces the risk of disease spreading among humans. Chlamydomonas reinhardtii chloroplast is an attractive platform for expressing malaria antigens because it is capable of folding complex proteins, including those requiring disulfide bond formation, while lack the ability to glycosylate proteins; a valuable quality of any malaria protein expression system, since the Plasmodium parasite lacks N-linked glycosylation machinery. In this study, Cell-traversal protein for ookinetes and sporozoites (CelTOS) antigen from Plasmodium falciparum was expressed in the chloroplast of C. reinhardtii and a highly sensitive and specific indirect ELISA test was developed using C. reinhardtii expressed PfCelTOS to detect malaria. Results obtained demonstrated that expressed recombinant PfCelTOS accumulates as a soluble, properly folded and functional protein within C. reinhardtii chloroplast and indirect ELISA using sera from malaria-positive donors suggested the potential use of expressed PfCelTOS as a malaria antigen for diagnosis tests.

Entities:  

Keywords:  Chlamydomonas reinhardtii; Malaria; Recombinant protein

Mesh:

Substances:

Year:  2019        PMID: 30506260     DOI: 10.1007/s12033-018-0140-1

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  21 in total

1.  The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics.

Authors:  Beth A Rasala; Stephen P Mayfield
Journal:  Bioeng Bugs       Date:  2011 Jan-Feb

2.  Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii.

Authors:  Carla S Jones; Tiffany Luong; Michael Hannon; Miller Tran; James A Gregory; Zhouxin Shen; Steven P Briggs; Stephen P Mayfield
Journal:  Appl Microbiol Biotechnol       Date:  2012-05-18       Impact factor: 4.813

Review 3.  Protein production using the baculovirus-insect cell expression system.

Authors:  A Contreras-Gómez; A Sánchez-Mirón; F García-Camacho; E Molina-Grima; Y Chisti
Journal:  Biotechnol Prog       Date:  2014 Jan-Feb

4.  Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii.

Authors:  Beth A Rasala; Machiko Muto; Philip A Lee; Michal Jager; Rosa M F Cardoso; Craig A Behnke; Peter Kirk; Craig A Hokanson; Roberto Crea; Michael Mendez; Stephen P Mayfield
Journal:  Plant Biotechnol J       Date:  2010-03-07       Impact factor: 9.803

Review 5.  Optimising yeast as a host for recombinant protein production (review).

Authors:  Nicklas Bonander; Roslyn M Bill
Journal:  Methods Mol Biol       Date:  2012

6.  Efficient recombinant protein production and secretion from nuclear transgenes in Chlamydomonas reinhardtii.

Authors:  Kyle J Lauersen; Hanna Berger; Jan H Mussgnug; Olaf Kruse
Journal:  J Biotechnol       Date:  2012-10-22       Impact factor: 3.307

7.  CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts.

Authors:  Tohru Kariu; Tomoko Ishino; Kazuhiko Yano; Yasuo Chinzei; Masao Yuda
Journal:  Mol Microbiol       Date:  2006-03       Impact factor: 3.501

8.  Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission.

Authors:  James A Gregory; Fengwu Li; Lauren M Tomosada; Chesa J Cox; Aaron B Topol; Joseph M Vinetz; Stephen Mayfield
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

9.  Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei.

Authors:  Elke S Bergmann-Leitner; Ryan M Mease; Patricia De La Vega; Tatyana Savranskaya; Mark Polhemus; Christian Ockenhouse; Evelina Angov
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

10.  The evil circle of poverty: a qualitative study of malaria and disability.

Authors:  Benedicte Ingstad; Alister C Munthali; Stine H Braathen; Lisbet Grut
Journal:  Malar J       Date:  2012-01-11       Impact factor: 2.979

View more
  5 in total

Review 1.  Emerging Trends in Genetic Engineering of Microalgae for Commercial Applications.

Authors:  Samir B Grama; Zhiyuan Liu; Jian Li
Journal:  Mar Drugs       Date:  2022-04-24       Impact factor: 6.085

Review 2.  Harnessing the Algal Chloroplast for Heterologous Protein Production.

Authors:  Edoardo Andrea Cutolo; Giulia Mandalà; Luca Dall'Osto; Roberto Bassi
Journal:  Microorganisms       Date:  2022-03-30

Review 3.  Isolation of Industrial Important Bioactive Compounds from Microalgae.

Authors:  Vimala Balasubramaniam; Rathi Devi-Nair Gunasegavan; Suraiami Mustar; June Chelyn Lee; Mohd Fairulnizal Mohd Noh
Journal:  Molecules       Date:  2021-02-10       Impact factor: 4.411

4.  A Dual, Systematic Approach to Malaria Diagnostic Biomarker Discovery.

Authors:  Seda Yerlikaya; Ewurama D A Owusu; Augustina Frimpong; Robert Kirk DeLisle; Xavier C Ding
Journal:  Clin Infect Dis       Date:  2022-01-07       Impact factor: 9.079

Review 5.  Recent Advancements and Future Perspectives of Microalgae-Derived Pharmaceuticals.

Authors:  Donghua Xia; Wen Qiu; Xianxian Wang; Junying Liu
Journal:  Mar Drugs       Date:  2021-12-12       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.